Presse

Ferring Strich weiss
In diesem Bereich unserer Webseite finden Sie die neuesten nationalen und internationalen Pressemitteilungen der FERRING-Gruppe sowie eine Sammlung von Presseartikel über unsere innovativen Präparate aus den Bereichen Reproduktionsmedizin, Urologie, chronisch entzündliche Darmerkrankungen, Endokrinologie und Geburtshilfe.

Wenn Sie Journalist/-in sind und Fragen zu FERRING oder zu unseren Arzneimitteln haben, wenden Sie sich gerne direkt an uns:

Frau Dr. Sibille Engels 
FERRING Arzneimittel GmbH 
Tel.: +49 431 58 52 106 
Fax: +49 431 58 52 441 
E-Mail: info-service@ferring.de

 

Friday, 10 March 2017

Ferring acquires ex-U.S. assets and rights for Vitaros® (alprostadil cream), Apricus’ on-demand topical cream for erectile dysfunction

Read press release

spacer ferring arzneimittel presse

 
Wednesday, 15 February 2017

Ferring Announces Recipients of Innovation Grants Program 2016-2017

Read press release

spacer ferring arzneimittel presse
Monday, 13 February 2017

Ferring and Foresee Pharmaceuticals Enter into Exclusive Development and Option Agreement

Read press release

spacer ferring arzneimittel presse
Monday, 30 January 2017

Ferring Pharmaceuticals and Enteris BioPharma Enter License Agreement to Develop an Oral Formulation of a Peptide-based Injectable Therapeutic

Read press release

spacer ferring arzneimittel presse
Tuesday, 13 December 2016

Ferring receives EU approval for REKOVELLE® (follitropin Delta)

Read press release

spacer ferring arzneimittel presse
Tuesday, 03 May 2016

Ferring Pharmaceuticals announces approval for NOCDURNA®, a new therapeutic option for the treatment of adults waking multiple times to urinate at night

Read press release

spacer ferring arzneimittel presse
Friday, 18 March 2016

Wake up to nocturia: The most common cause of disrupted sleep that could be damaging your health

Read press release

spacer ferring arzneimittel presse
Monday, 08 February 2016

Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide

Read press release

spacer ferring arzneimittel presse
Monday, 11 January 2016

Targeted Immuno Therapies AB and Ferring Pharmaceuticals sign a strategic collaboration agreement for the treatment of IBD

Read press release

spacer ferring arzneimittel presse
Monday, 14 December 2015

Cosmo & Ferring Pharmaceuticals enter into licensing agreement for CORTIMENT®MMX®(budesonide) in Japan

Read press release

spacer ferring arzneimittel presse
Friday, 11 December 2015

Ferring Pharmaceuticals submits variation application to introduce new tailored dosing regimen in the PICOPREP® (sodium picosulfate, magnesium oxide, citric acid) label

Read press release

spacer ferring arzneimittel presse
Friday, 30 October 2015

Ferring receives acceptance of Marketing Authorisation filing from EMA for personalised fertility treatment with REKOVELLE® (follitropin delta)

Read press release

spacer ferring arzneimittel presse
Monday, 28 September 2015

Ferring Pharmaceuticals acquires global rights to MILPROSA (progesterone vaginal ring)

Read press release

spacer ferring arzneimittel presse
Monday, 13 July 2015

Ferring Pharmaceuticals moves forward with early stage development of bacteriophage therapy for inflammatory bowel disease

Read press release

spacer ferring arzneimittel presse
Wednesday, 22 April 2015

Inflammatory Bowel Disease Treatment Gets Boost From New Educational Resource

Read press release

spacer ferring arzneimittel presse
Thursday, 16 April 2015

Ferring and the Institut Pasteur collaborate in novel IBD drug development project

Read press release

spacer ferring arzneimittel presse
Tuesday, 07 April 2015

Ferring announces European approval of new room temperature stable formulation of PABAL®(carbetocin)

Read press release

spacer ferring arzneimittel presse
Monday, 23 February 2015

Ferring Pharmaceuticals acquires novel drug delivery technology from CTCBIO Inc.

Read press release

spacer ferring arzneimittel presse
Friday, 20 February 2015

Ferring announces European launch of CORTIMENT®MMX® (budesonide) for ulcerative colitis, and new data re-confirms safety and efficacy

Read press release

spacer ferring arzneimittel presse
Wednesday, 18 February 2015

Ferring Pharmaceuticals acquires two phase III ready orthobiologic product candidates from BioSET

Read press release

spacer ferring arzneimittel presse
Tuesday, 27 January 2015

Ferring Pharmaceuticals moves to strengthen growth with appointment of Chief Medical and Chief Scientific officers

Read press release






Bildmaterial

Logo FERRING Arzneimittel

Download als JPG

Logo FERRING GmbH

Download als JPG



Haben Sie Fragen?

Ferring Strich weissSchreiben Sie uns einfach an info-service@ferring.de.

FERRING – für Sie da.

Ferring neu2006